Intuitive Surgical stock trades at EUR 380.75 with P/ E 48.4

Published on 10/12/2026 at 17:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock costs EUR 380.75 on October 12, 2026. Its P/E ratio is 48.44 and market value is USD 150.4 billion as of October 12, 2026.

Key points in brief

Intuitive Surgical stock was EUR 380.75 at Lang & Schwarz on October 12, 2026 at 5:00 p.m. CEST.
The company had a USD 150.4 billion market capitalization and a P/E ratio of 48.44.
Nasdaq data showed a USD 425.67 quote and a USD 328.57 to USD 603.88 52-week range.
The next Intuitive Surgical earnings conference call is scheduled for October 20, 2026.

Schwarzweiß-Reportagefoto eines Chirurgen an der Konsole während einer robotergestützten Operation — Dokumentarische Schwarzweiß-Reportage aus dem OP-Saal illustriert Intuitive Surgical Inc. (US46120E6023) und den Arbeitsalltag der Chirurgie-Robotik, Illustration mit AI erstellt.

Intuitive Surgical (ISIN US46120E6023) was trading at EUR 380.75 at Lang & Schwarz on October 12, 2026 at 5:00 p.m. CEST. The valuation snapshot showed a P/E ratio of 48.44 and a market capitalization of USD 150.4 billion, giving the price report a clear valuation focus.

Nasdaq quote at USD 425.67

On the Nasdaq, Intuitive Surgical was last at USD 425.67 on October 12, 2026 at 11:01 a.m. EDT. The quote was inside a 52-week range of USD 328.57 to USD 603.88, with both figures dated to the same market-data snapshot.

The two currency perspectives serve different purposes. EUR 380.75 is the German trading reference at Lang & Schwarz, while USD 425.67 is the home-market quote for ISRG on the Nasdaq.

Valuation has room for context

MarketBeat lists 31 analyst ratings from the last 12 months, including 21 Buy ratings, 8 Hold ratings, 1 Sell rating and 1 Strong Buy rating. Its average 12-month price target is USD 502.53.

Intuitive Surgical develops robotic-assisted surgical systems, instruments and related services. Its investor materials describe the da Vinci system as the company flagship and identify the Ion system as a platform for diagnostic lung biopsies.

Comparison with peers

Intuitive Surgical: , P/E 48.44, market capitalization USD 150.4 billion

Stryker (NYSE, USD): plus 0.5 percent, P/E 28.90, market capitalization USD 106.9 billion

Abbott Laboratories (NYSE, USD): plus 1.2 percent, P/E 32.40, market capitalization USD 174.3 billion

October 20 earnings call

The investor calendar lists the next Intuitive Surgical earnings conference call for October 20, 2026 at 1:30 p.m. PDT, giving the valuation figures a dated event to watch. The appointment is published on Intuitive Surgical's investor page.

The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.